Introduction: One pathological hallmark of Alzheimer's disease (AD) is atrophy of medial
temporal brain regions that can be visualized on magnetic resonance imaging (MRI), but not …

As a characteristic feature of Alzheimer´ s disease (AD) hippocampal atrophy (HA) can be
demonstrated in the majority of patients by using neuroimaging techniques in particular …

Atrophy patterns on MRI can reliably predict three neuropathological subtypes of
Alzheimer's disease (AD): typical, limbic-predominant, or hippocampal-sparing. A method to …

Background/Aims MRI assessment of the brain has demonstrated four different patterns of
atrophy in patients with Alzheimer's disease dementia (AD): typical AD, limbic-predominant …

Objective: To test the hypothesis that cortical and hippocampal volumes, measured in vivo
from volumetric MRI (vMRI) scans, could be used to identify variant subtypes of Alzheimer …

Background: Discrete clinical and pathological subtypes of Alzheimer's disease (AD) with
variable presentations and rates of progression are well known. These subtypes may have …

Objectives: To assess the diagnostic specificity of MRI-defined hippocampal atrophy for AD
among individuals with a variety of pathologically confirmed conditions associated with …

To accurately predict the development of Alzheimer's disease (AD) at its predementia stage
would be a major breakthrough from both therapeutic and research standpoints. In this …

The hippocampal formation (HF) is known from pathological and MRI studies to be severely
atrophied in established Alzheimer's disease. However, it is unclear when the earliest …

Objective The pathologic validation of European Alzheimer's Disease Consortium
Alzheimer's Disease Neuroimaging Initiative Center Harmonized Hippocampal …